
Health Catalyst, Inc.
Health Catalyst, Inc. (HCAT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HCAT · as of Jun 8, 2026
Key Statistics
Explore Health Catalyst, Inc. Data
hcat stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 22 · Buy rate: 54.5%
The HCAT analyst consensus is Buy, based on ratings from 22 Wall Street analysts over the past 3 months. The average 12-month price target is $2.25, representing +28.94% upside from the current price of $1.75.
Competitors & Peers
hcat competitorsStock Performance
Full HistoryAbout Health Catalyst, Inc.
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data a…
what is health catalyst, inc. · hcat stock overview · health catalyst, inc. company profile · who is health catalyst, inc. ceo · hcat NASDAQ · health catalyst, inc. headquarters · health catalyst, inc. business segments
About Stock Overview & Key Data
Health Catalyst, Inc. (HCAT) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NASDAQ since Jul 25, 2019. As of the latest trading session, HCAT stock price is $1.75, with a market capitalization of $128.9M. The stock has returned -58.05% over the past 12 months and -26.99% year-to-date.
According to 22 Wall Street analysts, the consensus rating for Health Catalyst, Inc. stock is Buy, with an average 12-month price target of $2.25. In fiscal year 2025, Health Catalyst, Inc. reported revenue of $311.1M and net income of -$178.0M. For detailed data — including Health Catalyst, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Health Catalyst, Inc. (HCAT) stock price is $1.75. The stock is traded on NASDAQ under the ticker symbol HCAT. The 52-week range is $0.95 – $4.29.